Details for Patent: 7,723,361

✉ Email this page to a colleague

Summary for Patent: 7,723,361

Title:	Methods for inhibiting undesired angiogenesis in patients having tumors with thalidomide
Abstract:	The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis and to treat disease states resulting from angiogenesis. Importantly, these compounds can be administered orally.
Inventor(s):	D'Amato; Robert (Lancaster, PA)
Assignee:	Celgene Corporation (Summit, NJ)
Application Number:	11/096,155
Patent Claim Types: see list of patent claims	Use; Dosage form;

Drugs Protected by US Patent 7,723,361

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 7,723,361

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0688211	⤷ Sign Up	91471	Luxembourg	⤷ Sign Up
European Patent Office	0688211	⤷ Sign Up	CA 2008 00034	Denmark	⤷ Sign Up
European Patent Office	0688211	⤷ Sign Up	300358	Netherlands	⤷ Sign Up
European Patent Office	0688211	⤷ Sign Up	SPC025/2008	Ireland	⤷ Sign Up
European Patent Office	0688211	⤷ Sign Up	SPC/GB08/039	United Kingdom	⤷ Sign Up
European Patent Office	0688211	⤷ Sign Up	C300358	Netherlands	⤷ Sign Up
European Patent Office	0688211	⤷ Sign Up	08C0036	France	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.